4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pulmonx Corporation (LUNG) operates in the Medical Devices industry and is headquartered in Redwood City, United States with about 296 employees. Its market capitalization is roughly $61 million. In the fiscal year ended 2025-12-31, LUNG reported $90M in revenue and ($54M) in net income.
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.
Interactive charts & full statements → Open the LUNG valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $90M | $84M | $69M | $54M |
| Gross Profit | $67M | $62M | $51M | $40M |
| Operating Income (EBIT) | ($54M) | ($58M) | ($62M) | ($59M) |
| Net Income | ($54M) | ($56M) | ($61M) | ($59M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $21M | $23M | $22M | $24M | $22M |
| Gross Profit | $16M | $18M | $16M | $17M | $16M |
| Operating Income (EBIT) | ($13M) | ($10M) | ($14M) | ($15M) | ($15M) |
| Net Income | ($14M) | ($10M) | ($14M) | ($15M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $129M | $163M | $178M | $194M | — |
| Total Liabilities | $75M | $77M | $60M | $40M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LUNG viewer.
About TickerBase · Data methodology & sources